Increased serum resistin level is associated with coronary heart disease.

Abstract

To explore the relationship between the serum resistin level and different types of coronary heart diseases (CHD). Literature was retrieved by formal searching of PubMed, Web of Science, Google Scholar, the Cochrane Library, Wanfang Data, China Biological Medicine Database (SinoMed) and China National Knowledge Infrastructure (CNKI) and by hand searching of reference lists of related articles. RevMan5.3 statistical software was utilized for processing and analysis. A total of 22 literatures involving 2070 subjects were included. Meta-analysis showed that the level of serum resistin in the patients with stable angina (SA), unstable angina(UA) or acute myocardial infarction (AMI) were significantly higher than those of normal controls, respectively [SMD(95% CI)were 1.97(1.15, 2.79), 2.54(1.76, 3.31), and 3.62(2.62, 4.62), all P<0.00001]. Serum resistin level in patients with UA or AMI was higher than those in patients with SA, respectively [SMD=0.90, 95CI(0.28,1.52), P=0.005], [SMD=2.28, 95%CI(0.74, 3.82), P=0.004].The level of serum resistin in patients with AMI was also higher than those in patients with UA [SMD=1.22, 95%CI(0.58, 1.85), P=0.0002]. The study demonstrated that increased serum resistin level is significantly associated with the severity of CHD.

• Authors: Jing-Zhan Zhang, Ying Gao, Ying-Ying Zheng, Fen Liu, Yi-Ning Yang, Xiao-Mei Li, Xiang Ma, Yi-Tong Ma, Xiang Xie
• Journal: Oncotarget (Oncotarget) Vol. 8 Issue 30 Pg. 50148-50154 (Jul 25 2017) ISSN: 1949-2553 [Electronic] United States
• PMID: 28404934 (Publication Type: Journal Article, Meta-Analysis)

Chemical References

• Resistin

Topics

• Coronary Disease (blood, pathology)
• Female
• Humans
• Male
• Resistin (adverse effects, blood)